On Oct. 18, 2022, global leaders confirmed US$ 2.6 billion in funding toward the Global Polio Eradication Initiative’s…
On Oct. 17, 2022, Moderna and Gavi, the Vaccine Alliance, announced they had mutually agreed to cancel remaining…
On Oct. 15, 2022, scientists reported that DNA evidence showed that the plague infection was endemic in the…
On Oct. 13, 2022, Pfizer and BioNTech announced early data from a Phase 2/3 clinical trial (NCT05472038) evaluating…
On Oct. 13, 2022, Novavax announced positive results from the Phase 1/2 clinical trial of its COVID-19-Influenza Combination…
On Oct. 13, 2022, a team of researchers led by Cornell University announced they had sequenced the Honeycrisp…
On Oct. 13, 2022, researchers from the University of Oxford reported findings from a study exploring how certain…
On Oct. 12, 2022, Moderna announced that it had received emergency use authorization from the U.S. Food and…
On Oct. 12, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced the Bezos family had committed $710.5 million…
On Oct. 12, 2022, scientists announced they had developed a research method that allows for a much more…
On Oct. 12, 2022, Pfizer and BioNTech announced that the U.S. Food and Drug Administration granted Emergency Use…
On Oct. 11, 2022, Roche announced the launch of its next-generation portfolio SARS-CoV-2 rapid antigen tests (ﾓ2.0ﾔ) for…
On Oct. 11, 2022, researchers from the University of Oxford have reported new findings from a Phase 1…
On Oct. 10, 2022, the Mayo Clinic announced that The Fred C. and Katherine B. Andersen Foundation of…
On Oct. 10, 2022, Novavax announced that Switzerland’s Federal Office of Public Health had recommended Nuvaxovid (NVX-CoV2373) as…
On Oct. 10, 2022, Novavax announced that partner, SK bioscience, had submitted a Post Approval Change Application to…
On Oct. 7, 2022, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to…
On Oct. 7, 2022, the U.S. Food and Drug Administration approved Boostrix (Tetanus Toxoid, Reduced Diphtheria Toxoid and…
On Oct. 7, 2022, the National Eye Institute researchers announced they had mapped the organization of human retinal…
On Oct. 7, 2022, Pfizer and BioNTech announced that Health Canada had authorized COMIRNATY Original & Omicron BA.4/BA.5…
On Oct. 7, 2022, the U.S. Department of Agricultures Animal Plant Health Inspection Service (APHIS) confirmed the presence…
On Oct. 6, 2022, researchers in Japan released a study that described the development and application of the…
On Oct. 6, 2022, the World Health Organization announced the first cholera outbreak in nearly three decades in…
On Oct. 6, 2022, Merck announced data from two real-world evidence studies evaluating LAGEVRIOﾙ (molnupiravir), an investigational oral…
On Oct. 5, 2022, the Nobel Prize in Chemistry was awarded jointly to Carolyn R. Bertozzi, Morten Meldal…
On Oct. 5, 2022, researchers at UC Berkeley reported that coccidioidomycosisﾗalso known as Valley feverﾗan infectious disease, was…
On Oct. 4, 2022, Washington University in St. Louis announced it had licensed the rights to develop, manufacture…
On Oct. 4, 2022, the United States Department of Agriculture’s (USDA) Agricultural Research Service (ARS), Southeast Poultry Research…
On Oct. 3, 2022, the Nobel Prize in Physiology or Medicine was awarded to was awarded to Svante…
On Oct. 3, 2022, Monica M. Bertagnolli, M.D., started as the 16th director of the National Cancer Institute….